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Abstract
Background: Left ventricular (LV) mass and wall thickness are closely associated with measures of body size and blood
pressure and also correlated with systolic and diastolic function, suggesting a contribution of common physiologic
mechanisms, including pleiotropic genes, to their covariation.
Methods: Doppler echocardiography was performed in 434 African-American (1344 individuals) and 284 white families
(1119 individuals). We conducted a genome-wide linkage scan for LV mass, LV structure and function, and composite
factors derived from a factor analysis of LV structure and function in the HyperGEN Study population.
Results: Factor analysis identified (i) a LV wall thickness factor correlated strongly with interventricular septal thickness
(IVSTd) and posterior wall thickness (PWTd) and (ii) a LV diastolic filling factor strongly correlated with early and atrial
phase peak transmitral filling velocities. The LV phenotypes and composite factor scores were analyzed in multipoint
variance components linkage model implemented in SOLAR with 387 microsatellite markers. In whites, the two highest
LODs were 3.42 for LV atrial phase peak filling velocity at 144 cM on chromosome 1 and 3.12 for the LV wall thickness
factor at 160 cM on chromosome 7. The peak LODs of the component traits (IVSTd and PWTd) clustered at the same
region as the composite factor. Adjusting the factor score for body mass index (BMI) substantially reduced the peak LOD
at this region (LOD = 1.92). Bivariate linkage analysis of the composite factor with BMI improved LOD to 3.42 at 158
cM. Also in whites, suggestive linkage was observed on chromosomes 2 and 4 for LV mass, chromosomes 3, 5, 10, and
17 for LV atrial phase peak filling velocity, and chromosome 10 for LV diastolic filling factor. In African Americans,
suggestive linkage was observed on chromosome 12 for LV mass, chromosome 21 for IVSTd, and chromosome 3 for LV
internal diameter at end-diastole.
Conclusion: Our study suggests that a region on chromosome 7 contains pleiotropic genes contributing to the
variations of both LV wall thickness and BMI in whites.
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Background
Left ventricular hypertrophy (LVH), due to thickening of
LV walls and/or LV chamber enlargement, is a strong pre-
dictor of cardiovascular mortality and morbidity [1].
Increase of LV mass is considered to be a compensatory
process to maintain systolic LV wall stress in response to
physiological and pathological stimuli such as body
growth, obesity, and hypertension [2]. Therefore, LV mass
and wall thickness are closely associated with measures of
body size and blood pressure [3,4]. In addition, LV mass,
geometric pattern, and systolic and diastolic function are
inter-correlated [5-7], suggesting common physiological
links and/or shared genetic influences.
Genetic influences have been demonstrated for measures of
LV mass, wall thickness, and function [8-10]. In the Hyper-
tension Genetic Epidemiology Network (HyperGEN) study,
bivariate genetic analyses of LV diastolic function with LV
structure and systolic function detected shared genetic/famil-
ial influences between LV transmitral early (MVE) and atrial
phase peak filling velocities (MVA) in both African-American
and white hypertensive sibships [8]. In another study, a
bivariate genetic analysis of pubertal twins reported com-
mon genetic factors for LV mass and weight, explaining more
than 90% of correlation between the two traits [9].
Factor analysis is a multivariate data reduction technique
that derives latent phenotypes by identifying variation
common to a set of correlated variables. It has been
shown to be a useful tool in genetic studies to localize
genomic regions contributing to clustering of correlated
traits, such as metabolic syndrome-related risk variables
[11]. In the present study, we conducted a multipoint var-
iance-components linkage analysis of LV mass, LV struc-
ture and function, and composite factors derived from
factor analysis of LV structure and function, based on data
from families participating in the National Heart, Lung,
and Blood Institute (NHLBI) HyperGEN Study. Further-
more, we applied bivariate linkage analysis to investigate
pleiotropic loci contributing to the correlation between a
composite LV wall thickness factor and body mass index
(BMI), and between MVA and heart rate.
Methods
Population
HyperGEN is one of four Family Blood Pressure Program
networks supported by the NHLBI to identify genetic con-
tributions to hypertension [12]. Hypertensive sibships
were drawn from population-based cohorts or from the
community-at-large. Eligible hypertensive siblings had
onset of hypertension by age 60 years and at least one
hypertensive sibling who was willing to participate.
Hypertension was defined as average systolic blood pres-
sure (SBP) ≥ 140 mm Hg or average diastolic blood pres-
sure (DBP) ≥ 90 mm Hg on at least two different
evaluations, or treatment for hypertension. In its second
phase, HyperGEN recruited offspring of the hypertensive
siblings. The Genetics of Left Ventricular Hypertrophy
Study, a study ancillary to HyperGEN, performed echocar-
diography in four HyperGEN centers (Minneapolis, MN;
Salt Lake City, Utah; Forsyth County, NC; and Birming-
ham, AL). The Institutional Review Board of participating
institutions approved the protocol and all participants
gave informed consent. Included in the study are 1344
African Americans (913 hypertensive siblings and 431 off-
spring) and 1119 whites (589 hypertensive siblings and
530 offspring) who had complete data on echocardiogra-
phy phenotypes and genetic markers.
Echocardiography
Two-dimensionally (2D) guided M-mode, 2D and Dop-
pler echocardiograms were performed following a stand-
ardized protocol developed at the Echocardiography
Reading Center at the New York Hospital-Cornell Medical
Center [13]. Measurements were made at the central
echocardiography core lab as previously described [8]. LV
wall thickness and dimension at end-diastole, including
LV internal diameter (LVIDd), posterior wall thickness
(PWTd), and interventricular septal thickness (IVSTd),
were measured according to American Society of Echocar-
diography recommendations [14,15]. Relative wall thick-
ness (RWT) was calculated by 2*PWTd/LVIDd. LV mass
was calculated by an anatomically validated formula that
yields values closely correlated with necropsy LV weight (r
= 0.90) [16].
LV systolic function was assessed by stress-corrected mid-
wall fractional shortening (MWS). LV diastolic filling
parameters were measured by pulsed Doppler in apical
four chamber view. MVE and MVA obtained at the mitral
valve leaflet tips were used in the analysis.
The reading center has reported good reproducibility of
LV measurements by a protocol identical to that used in
the HyperGEN (e.g. intraclass correlation coefficients =
0.85 for IVSTd, 0.87 for LVIDd, 0.83 for PWTd, 0.71 for
MWS, 0.58 for MVE, and 0.57 for MVA) [17].
Genotyping
A total of 387 polymorphic markers (Cooperative Human
Linkage Center Screening set 8) spaced an average of 9.7
cM apart were genotyped by the Marshfield Clinic's
Center for Medical Genetics-Mammalian Genotyping
Service in Marshfield, WI. A high-throughput scanning
fluorescence detector system was used to genotype short
tandem repeat polymorphisms. The average heterozygos-
ity of the markers was 0.76. Marker consistency with Men-
delian expectations within families was tested using
ASPEX [18], and only confirmed relatives with marker
compatibility were used in the linkage analysis.BMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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Statistical Analysis
Comparison of distributions of demographic and clinical
characteristics between race groups was made by general-
ized estimating equations, which account for familial
relatedness. Prior to linkage and factor analyses, each LV
variable was adjusted for age, age2, and gender in race-
and generation-specific linear regression models. Residu-
als from the linear models were standardized to zero
mean and unit variance in each of the four race-by-gener-
ation groups. The standardized residuals were included in
linkage and factor analyses stratified by race. Participants
were excluded from factor analyses if their standardized
residuals were ≥ 5 standard deviations (SD) from the
means. For linkage analysis, a more stringent exclusion (>
4 SD) was used since linkage analysis is more sensitive to
the influence of outliers.
A maximum likelihood-based factor analysis was applied to
the residuals of PWTd, IVSTd, LVIDd, stress-corrected MWS,
MVA, MVE, and isovolumic relaxation time (IVRT). Details
of factor analysis modeling can be found in a supplement
(see Additional file 1). In the initial factor analysis of the
seven variables, two factors were retained by the eigenvalue
≥ 1.0 criteria and factor loading pattern was consistent
between African Americans and whites (see Table S1 of Addi-
tional file 1). The first factor had major factor loadings (>
0.4) with PWTd, IVSTd, and stress-corrected MWS and the
second factor with MVA and MVE. LVIDd and IVRT corre-
lated weakly with both factors (factor loading < 0.4). To
increase the relative contribution of the retained factors and
reduce noise from variables with small loadings on the fac-
tors, LVIDd and IVRT were excluded from the final factor
analysis models. Finally, factor scores, corresponding to the
estimated values of the underlying factors, were calculated
for each individual based on the final factor pattern and the
values of observed phenotypes. To reduce kurtosis, partici-
pants with factor scores more than 4 SD from the mean were
removed. The final factor scores were approximately nor-
mally distributed (both skewness and kurtosis < 0.6) and
included in linkage analysis.
Race-stratified multipoint linkage analysis was performed
using the variance components approach implemented in
Sequential Oligogenic Linkage Analysis Routines
(SOLAR) [19]. Details of linkage analysis can be found in
the supplement (see Additional file 1). Prior to the linkage
analysis, multipoint IBD statistics were computed sepa-
rately for African Americans and whites by GENE-
HUNTER version 2.1 [20] and used in the SOLAR linkage
analysis. The linkage analysis was conducted for both the
individual LV phenotypes and the composite factor
scores.
In the linkage analysis, LV phenotypes and factor scores
were first analyzed without covariate adjustments. Since
these variables have been adjusted for age, age2, and gen-
der prior to the factor analysis, the linkage model without
covariate adjustment is referred to as minimally adjusted
model. Secondly, the following covariates were adjusted
for in linkage analysis and this model is referred to as
maximally adjusted model: BMI, SBP, diabetes, and cur-
rent smoking. Heart rate was included in the maximally
adjusted model for MVA, MVE, and the factor related to
LV diastolic filling parameters. In addition, when a LOD
score from the maximally adjusted model was substan-
tially reduced compared to the minimally adjusted model
at a position where the minimally adjusted LOD score was
above 3.0, each of the covariates was adjusted for sepa-
rately to delineate the influence of individual covariate
adjustment on the linkage signal.
In the above analysis, if adjustment for an individual cov-
ariate had important influence on the LOD score for a LV
phenotype, it is possible that this indicates pleiotropic
genetic effects between the phenotype and covariate. To
test this hypothesis, bivariate linkage analyses [21] were
conducted between the corresponding phenotype and
individual covariate (i.e., BMI and heart rate, as discussed
below) on chromosomes where strong linkage signals
(i.e., LOD > 3) were obtained in minimally adjusted mod-
els and substantial reduction in LOD scores was observed
after the covariate adjustment. In addition, bivariate link-
age analyses were also conducted among component phe-
notypes on chromosomes where the corresponding
composite factor showed strong linkage (i.e., LOD > 3). In
SOLAR, an in-house algorithm was implemented to auto-
matically convert the two degrees of freedom (df) bivari-
ate LOD score to a one df equivalent LOD score. Details
of the bivariate linkage model can be found in the supple-
ment (see Additional file 1).
Finally, the SOLAR "lodadj" procedure was used to esti-
mate empirical single-point p-values for the observed uni-
variate and bivariate LODs. Details on this procedure can
be found in the supplement (see Additional file 1).
Results and discussion
Table 1 presents descriptive statistics for clinical and
echocardiographic measures by race. All of the risk factors
listed in Table 1 differed significantly between African
Americans and whites. Family structures are shown in
Table 2. On average, white families were larger than Afri-
can-American families, yielding more relative pairs than
African-American families.
Table 3 presents factor-loading patterns from the final fac-
tor analysis models. In both race groups, two factors were
retained with the eigenvalue ≥ 1.0 criterion. A likelihood
ratio test showed that two factors were sufficient to
explain the covariance among the five variables (p = 0.5 inBMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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whites and 0.8 in African Americans for testing the null
hypothesis that two factors are sufficient). The first factor
explained 66% of common variance and 41% of total var-
iance in African Americans, and 66% and 39% in whites,
respectively. The percentage of common and total vari-
ances explained by the second factor was 33% and 20%,
respectively, in African Americans, and 34% and 20%,
respectively, in whites. Since the first factor correlated
strongly with PWTd and IVSTd and the second factor with
MVA and MVE, the first factor is labeled a "LV wall thick-
ness factor" and the second labeled a "LV diastolic filling
factor."
Estimates of heritability ± SE for the LV phenotypes are
presented in Table 4.
Plots for whole genome linkage analysis of the LV struc-
ture and function including LV mass are presented in Fig-
ures S1 and S2 of the supplements (see Additional files 2,
3 and 4). Table 5 presents phenotypes and chromosomal
regions that showed peak LOD > 2.0 from at least one
adjustment model. In whites, LV wall thickness factor and
MVA showed strongest linkage signals. For the LV wall
thickness factor, we observed a highest LOD score of 3.12
(empirical p-value = 0.0002) at 160 cM on chromosome
7 between markers D7S2195 (155 cM) and GATA189C06
(163 cM) in whites. The 1-LOD-unit support interval
extends from 154 cM to 167 cM. Adjustment for BMI, SBP,
diabetes, and current smoking attenuated the LOD score
to 2.24. Among the four covariates, adjustment for BMI
was responsible for the reduction in LOD score at this
location (LOD = 1.92 after additional adjustment for
BMI); adjustment for covariates other than BMI did not
result in material change in the LOD (LOD: 3.05 – 3.39).
For MVA, a maximum LOD of 3.42 (empirical p-value =
0.00005) was obtained at 144 cM on chromosome 1.
Adjustment for the five covariates reduced the LOD score
to 2.32. The reduction in LOD was mainly due to the
adjustment for heart rate: LOD = 2.50 after additional
adjustment for heart rate; adjustment for other covariates
than heart rate did not materially change the LOD score
(LOD: 3.20 – 3.45). Also in whites, the LV diastolic filling
factor showed a suggestive linkage at 28 cM on chromo-
some 10 (LOD = 2.05) (Table 5). The component pheno-
types MVE and MVA both peaked at the same location,
Table 1: Characteristics of Study Sample: Means ± SD or Percentage (%)
African American
(n = 1344)
White
(n = 1119)
P*
Age, years 44.9 ± 13.5 49.2 ± 13.9 < 0.0001
Females, % 65.5 50.6 < 0.0001
Weight, kg 89.9 ± 22.4 84.5 ± 18.3 < 0.0001
Height, cm 167.6 ± 9.0 170.0 ± 9.3 0.039
Body mass index, kg/m2 32.0 ± 7.5 29.2 ± 5.9 < 0.0001
Systolic blood pressure, mm Hg 128.9 ± 22.0 122.9 ± 18.7 < 0.0001
Diastolic blood pressure, mm Hg 74.0 ± 11.6 70.8 ± 9.9 < 0.0001
# Hypertensive medication 0.95 ± 0.99 0.75 ± 0.89 < 0.0001
Ejection fraction, % 61.4 ± 7.9 61.9 ± 7.4 0.0147
Interventricular septal thickness, cm 0.92 ± 0.14 0.88 ± 0.13 < 0.0001
Posterior wall thickness, cm 0.86 ± 0.13 0.81 ± 0.13 < 0.0001
Relative wall thickness 0.33 ± 0.06 0.32 ± 0.05 < 0.0001
Left ventricular mass index, g/m2.7 41.7 ± 12.1 37.4 ± 10.7 < 0.0001
LV transmitral atrial phase peak filling velocity, cm/sec 72.4 ± 20.2 65.8 ± 18.4 < 0.0001
LV transmitral early peak filling velocity, cm/sec 81.5 ± 18.5 72.8 ± 17.6 < 0.0001
Stress-corrected midwall shortening, % 106.6 ± 12.9 109.6 ± 13.1 < 0.0001
Hypertension, % 71.6 55.9 < 0.0001
Diabetes, % 16.4 9.8 < 0.0001
Current smoking, % 27.4 10.1 < 0.0001
*for age and sex, test was adjusted for familial clustering; for other variables, test was adjusted for age, sex and familial clustering.
Table 2: Distribution of Family Structures
African American White
Number of families 434 284
Family size: average (range) 3.1 (2–10) 3.9 (2–12)
Number of individuals 1344 1119
Sib pairs 685 937
Half-sib pairs 180 17
Parent-child pairs 363 415
Avuncular pairs 412 618
Half avuncular 92 14
1st cousins 107 237
Half 1st cousins 34 0
Grandparent-grandchild 8 2
Grand avuncular 6 0
Half grand avuncular 2 0
Total relative pairs 1889 2240BMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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with a peak LOD of 1.11 for MVA and 1.60 for MVE.
Adjustment for the five covariates did not result in appre-
ciable changes in the LOD scores (data not shown).
Multipoint linkage results for the LV wall thickness factor
were compared to LOD plots from univariate and bivari-
ate linkage analyses of the three major component pheno-
types at their peak LOD locations on chromosome 7
(Figure 1). The univariate peak LODs of the three pheno-
types clustered around the same region as the composite
factor: 2.51 for PWTd at 161 cM, 1.83 for IVSTd at 159 cM,
and 0.44 for stress-corrected MWS at 162 cM. The peak
LODs for PWTd and IVSTd were significant at p < 0.05
(corresponding to LOD > 0.59 without regard to multiple
tests). Consistent with the univariate linkage results, the
bivariate LOD plots also clustered at this region: peak
LOD was 2.06 for PWTd-IVSTd at 160 cM, 2.33 for PWTd-
MWS at 161 cM, and 1.93 for IVSTd-MWS at 160 cM (Fig-
ure 1).
Bivariate genetic analysis between LV wall thickness factor
and BMI found significant genetic (0.28 ± 0.11, p < 0.05)
and environmental (0.26 ± 0.09, p < 0.05) correlations
between the two phenotypes. Based on these correlations,
the proportion of total additive genetic variance and envi-
ronmental variance that is due to shared genes and shared
environment was estimated as 7.8% (i.e., 0.282) and 6.8%
(i.e., 0.262), respectively. LOD plots from bivariate and
univariate linkage analyses on chromosome 7 are shown
in Figure 2. The peak LOD score from bivariate linkage
analysis of LV wall thickness factor with BMI was 3.42
(empirical p = 0.00008) at 158 cM, being stronger than
the univariate LOD scores of the two individual traits
(LOD = 0.82 for BMI at 156 cM). For the QTL at this loca-
tion, the hypothesis of ρQ = 0 was rejected (p = 0.0004)
and that of ρQ = 1 could not be rejected (p = 1.0). In the
bivariate linkage analysis, further adjustment for SBP,
smoking, and diabetes slightly increased the peak LOD to
3.57 (empirical p = 0.00008) at the same location.
Table 3: Factor Loading Pattern in the Final Factor Analysis Models
African American White
Variables Factor 1 Factor 2 Factor 1 Factor 2
LV posterior wall thickness 0.95 0.01 0.93 0.03
Interventricular septal thickness 0.91 0.03 0.89 0.05
Stress-corrected midwall shortening -0.57 0.11 -0.53 0.07
LV transmitral atrial phase peak filling velocity 0.06 0.50 0.08 0.46
LV transmitral early peak filling velocity -0.07 0.88 -0.10 0.89
Common variance 2.07 1.04 1.97 1.02
% common variance 66.6 33.4 65.9 34.1
% total variance 41.4 20.8 39.4 20.4
Factor 1, named LV wall thickness factor;
Factor 2, named LV diastolic filling factor.
Table 4: Estimates of Heritability ± SE for LV Structure and Function Phenotypes in African American and White Families
Phenotype African American White
Min Adj* Max Adj** Min Adj* Max Adj**
Interventricular septal thickness 0.33 ± 0.07 0.29 ± 0.07 0.42 ± 0.07 0.42 ± 0.07
LV internal diameter 0.51 ± 0.07 0.46 ± 0.07 0.41 ± 0.07 0.37 ± 0.07
Posterior wall thickness 0.33 ± 0.07 0.29 ± 0.07 0.41 ± 0.07 0.40 ± 0.07
Relative wall thickness 0.25 ± 0.07 0.23 ± 0.07 0.54 ± 0.07 0.56 ± 0.07
LV Mass 0.57 ± 0.07 0.58 ± 0.07 0.46 ± 0.07 0.35 ± 0.07
LV transmitral atrial phase peak filling velocity† 0.40 ± 0.07 0.43 ± 0.07 0.40 ± 0.07 0.33 ± 0.07
LV transmitral early peak filling velocity† 0.44 ± 0.07 0.44 ± 0.07 0.43 ± 0.07 0.43 ± 0.07
Stress-corrected midwall shortening 0.26 ± 0.07 0.26 ± 0.07 0.13 ± 0.07 0.11 ± 0.06
LV wall thickness factor 0.36 ± 0.07 0.33 ± 0.07 0.44 ± 0.07 0.44 ± 0.07
LV diastolic filling factor† 0.49 ± 0.07 0.49 ± 0.07 0.45 ± 0.07 0.44 ± 0.07
Estimates of heritability for all traits are significant at p < 0.05;
*Adjusted for age, age2, and gender;
**Additionally adjusted for BMI, SBP, diabetes, current smoking, and heart rate (for variables labeled with † only).BMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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There are also significant genetic (0.39 ± 0.11, p < 0.05)
and environmental (0.21 ± 0.08, p < 0.05) correlations
between MVA and heart rate after adjusting for age, age2,
and gender. However, bivariate linkage analysis of MVA
with heart rate on chromosome 1 yielded a lower LOD
(peak LOD = 2.38 at 145 cM) than the single-trait LOD for
MVA. Heart rate alone did not show linkage signal at this
region (LOD = 0), suggesting that the strong linkage signal
observed for MVA in the minimal adjustment model was
likely confounded by loading condition measured by
heart rate.
To our knowledge, our study is the first to apply a factor
analysis approach to investigate the multivariate correla-
tion architecture underlying LV wall thickness, dimen-
sion, and systolic and diastolic function. Furthermore, we
conducted a multipoint genome-wide scan for the com-
posite factor scores derived from the factor analysis mod-
els to localize genetic loci contributing to the clustering of
these traits. We observed measures for LV wall thickness
(PWTd and IVSTd) strongly loaded on a factor that was
also associated with LV systolic function measured by
stress-corrected MWS; LV diastolic filling parameters
loaded on a different factor. In the linkage analysis, we
identified regions on chromosomes 7q36 and 1p13 that
showed strong linkage for the LV wall thickness factor and
MVA, respectively. The linkage evidence for LV wall thick-
ness factor is further strengthened by the fact that both
individual measures of wall thickness strongly mapped to
the same region. This locus had pleiotropic effects on
body size as measured by BMI. Based on the genome-wide
significance criteria (p = 0.000049 and LOD ≥ 3.3) pro-
posed by Lander and Kruglyak [22], the LOD for MVA in
minimally adjusted model reached genome-wide signifi-
Table 5: Peak Multipoint LOD Scores and Flanking Markers for Regions with LOD > 2.0 from at Least One Adjustment Model in 
African Americans and Whites
Trait Model Chr Pos (cM*) LOD/p† Flanking Markers (cM*)
African Americans
IVSTd Min 21 37 1.32/0.0066 ATA27F01 (37)
IVSTd Max1 21 38 2.17/0.0005 ATA27F01 (37)/GATA188F04 (40)
LVIDd Min 3 36 2.30/0.0006 AFM036YB8 (37)
LVIDd Max1 3 36 2.16/0.0012 AFM036YB8 (37)
LVM Min 12 18 1.18/0.0109 GATA49D12 (18)
LVM Max1 12 19 2.13/0.0011 GATA49D12 (18)/GATA11H08 (26)
LVM Max3 12 18 1.54/0.0051 GATA49D12 (18)
Whites
LVM Min 2 170 2.40/0.0004 ATA27H09 (165)/GATA71D01 (173)
LVM Max1 2 169 1.96/0.0010 ATA27H09 (165)/GATA71D01 (173)
LVM Max3 2 170 1.94/0.0011 ATA27H09 (165)/GATA71D01 (173)
LVM Min 4 43 2.34/0.0004 ATA27C07 (43)
LVM Max1 4 43 1.79/0.0019 ATA27C07 (43)
LVM Max3 4 43 1.86/0.0016 ATA27C07 (43)
PWTd Min 7 161 2.51/0.0003 D7S2195 (155)/GATA189C06 (163)
PWTd Max1 7 162 1.59/0.0028 D7S2195 (155)/GATA189C06 (163)
LV wall thickness factor Min 7 160 3.12/0.0002 D7S2195 (155)/GATA189C06 (163)
LV wall thickness factor Max1 7 161 2.24/0.0008 D7S2195 (155)/GATA189C06 (163)
MVA Min 1 144 3.42/0.00005 ATA29D04 (137)/GATA12A07 (152)
MVA Max2 1 141 2.32/0.0006 ATA29D04 (137)/GATA12A07 (152)
MVA Min 3 26 2.28/0.0005 GATA164B08 (26)
MVA Max2 3 27 2.94/0.0002 GATA164B08 (26)
MVA Min 5 148 2.56/0.0003 ATA23A10 (148)
MVA Max2 5 148 2.05/0.0012 ATA23A10 (148)
MVA Min 10 72 2.17/0.0008 ATA5A04 (63)/AFM329xa9 (76)
MVA Max2 10 92 2.35/0.0006 GATA121A08 (88)/GATA87G01 (94)
MVA Min 17 54 2.13/0.0008 GGAA9D03 (51)/GGAA7D11 (57)
MVA Max2 17 55 2.27/0.0007 GGAA9D03 (51)/GGAA7D11 (57)
LV diastolic filling factor Min 10 28 2.05/0.0017 ATA31G11 (28)
LV diastolic filling factor Max2 10 28 1.85/0.0024 ATA31G11 (28)
IVSTd = interventricular septal thickness at end-diastole, LVIDd = LV internal diameter at end-diastole, LVM = LV mass, MVA = LV transmitral atrial 
phase peak filling velocity, PWTd = LV diastolic posterior wall thickness; *in Kosambi distance; †empirical p value based on simulation;
Min: adjusted for age, age2, and gender;
Max1: additionally adjusted for BMI, SBP, diabetes, and current smoking;
Max2: additionally adjusted for heart rate, BMI, SBP, diabetes, and current smoking;
Max3: additionally adjusted for BMI.BMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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cance after correcting for multiple testing. The bivariate
LODs for LV wall thickness factor with BMI in both mini-
mally and maximally adjusted models reached borderline
significance at the genome-wide level. The strong linkage
signal observed for MVA on chromosome 1 was likely
confounded by loading condition, as suggested by the
results of multivariate adjustment and bivariate linkage
analyses with heart rate. It is important to note that the
strong linkage evidence obtained in this study needs to be
replicated in other populations to validate the linkage
findings and rule out false positives. Future gene discovery
efforts may not be justified before proper replication is
obtained.
At the region on chromosome 7 where the LV wall thick-
ness factor showed strong linkage in whites, LV mass
peaked at approximately the same location but with weaker
signal in the same population: peak LOD was 0.44 at 156
cM and 0.14 at 155 cM in the minimally and maximally
adjusted models, respectively. The difference in magnitude
of linkage signal between LV mass and the LV wall thick-
ness factor is likely due to the fact that the locus at this loca-
tion is mainly for LV wall thicknesses, which is captured at
a larger extent by the wall thickness factor than LV mass.
Mathematically, the formulae for LV mass [16] includes
both wall thickness (IVSTd and PWTd) and dimension
(LVIDd) while the LV wall thickness factor is mainly deter-
mined by wall thickness. With similar measures of wall
thickness, the value of LV mass can differ substantially
depending on LV dimension or the extent of LV remodeling
(i.e., LV wall thickness relative to dimension). Accordingly,
the correlation between LV mass and the LV wall thickness
factor is lower (0.66 in whites and 0.71 in African Ameri-
cans after adjustment for age and gender) compared to the
correlation between the LV wall thickness factor and indi-
vidual measures of LV wall thickness (correlation > 0.90 in
both race groups) (see Table S3 of Additional file 1).
In addition to the strong linkage signals for the LV com-
posite factor scores, we also observed suggestive linkage
for LV mass and other structure phenotypes on other chro-
mosomes (Table 5). Mayosi et al conducted a genome-
wide linkage analysis of electrocardiographic (ECG) and
echocardiographic LV phenotypes in 224 white British
families (868 individuals) ascertained through a hyper-
tensive proband [23]. In that study, suggestive evidence
for linkage was obtained for ECG LV mass on chromo-
somes 7 (LOD = 1.67 at 120 cM) and 12 (LOD = 2.19 at
78 cM), and for echocardiographic LV mass on chromo-
some 5 (LOD = 1.6 at 40 cM) [23]. At the three locations,
the strongest linkage signal we observed for LV mass in
whites of our study was on chromosome 12: peak LOD
was 0.93 at 99 cM and 1.28 at 95 cM in the minimally and
maximally adjusted models, respectively.
Our observation that LV diastolic filling parameters mainly
loaded on a different factor than LV wall thickness and systo-
lic function may reflect differences in the underlying physio-
logic mechanisms regulating LV diastolic and systolic
function. Specifically, the primary physiologic determinant
of systolic function is myocardial contractility, whereas it is
myocardial relaxation and effective chamber compliance
that influence LV diastolic early and late filling, respectively
[24-26]. At the cellular level, myocardial contraction and
relaxation are related to different phases of cytoplasmic cal-
Multipoint linkage plots for LV wall thickness factor and uni- variate and bivariate linkage plots for its major component  variables on chromosome 7 in whites Figure 1
Multipoint linkage plots for LV wall thickness factor 
and univariate and bivariate linkage plots for its 
major component variables on chromosome 7 in 
whites. Logarithm of odds (LOD) scores (y-axis) and their 
respective cM (x-axis) from the p-telomere (left) to the q-tel-
omere (right) are shown. PWTd = posterior wall thickness, 
IVSTd = interventricular septal thickness, c-MWS = stress-
corrected midwall shortening.
Bivariate and univariate linkage plots for LV wall thickness  factor and body mass index (BMI) Figure 2
Bivariate and univariate linkage plots for LV wall 
thickness factor and body mass index (BMI). Same 
labels for x- and y- axes as in Figure 1.BMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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cium cycling, with the former dependent on release of cal-
cium from sarcoplasmic reticulum (SR) via the calcium
release channels and the latter dependent on reuptake of cal-
cium into the SR by the SR-calcium-ATPase pump which is
modulated by phospholamban [25,26]. While preload
(approximated by heart rate and stroke volume) and after-
load (approximated by SBP, DBP, and stroke volume) con-
ditions might be the driving force for the formation of the
separate LV diastolic filling factor, this factor had weak corre-
lations with heart rate (whites: -0.06; AAs: -0.09), SBP
(whites: 0.06; AAs: 0.07), DBP (whites: -0.05; AAs: -0.06),
and stroke volume (whites: 0.13, AAs: 0.18), suggesting that
preload and afterload conditions are unlikely the underlying
mechanism responsible for the clustering of the LV diastolic
filling parameters.
Since body size is an important correlate of LV mass, it is pos-
sible that there are pleiotropic genes contributing to these
two phenotypes. In our study, the genetic correlation
between LV mass and BMI was 0.35 ± 0.08 (p < 0.05) in Afri-
can Americans and 0.57 ± 0.09 (p < 0.05) in whites after
adjustment for age, age2, and gender. These data agree with
evidence from other genetic studies of LV mass with body
size in twins and families [9,27]. For example, Verhaaren et
al conducted a bivariate genetic analysis in 341 twins of 11
years old and detected a substantial influence of common
genetic factors for the clustering of LV mass and weight,
explaining more than 90% of correlation between these
traits [9]. In a study of 149 nuclear families comprising
healthy adults and children, genetic and/or familial factors
accounted for all of the correlation between LV mass and
weight in adults and 59% of the correlation in children [27].
Our study further extends these findings by providing evi-
dence for a genetic locus on chromosome 7 that had pleio-
tropic effects on LV wall thickness and body size. It is
important to note that this region has previously been linked
to stature and obesity measures in other studies. For height,
the peak LOD score was 3.40 at marker D7S2195 (155 cM)
in a Swedish population [28] and 2.91 at D7S1826 (162 cM)
in a Finnish population [29]. In the HERITAGE Family
Study, marker D7S3070 (163 cM) and a marker within the
NOS3 gene (164 cM) were reportedly linked to change in
abdominal total fat in response to exercise with LODs of
2.53 and 2.34, respectively [30]. In our study, the univariate
LOD score for height and bivariate LOD score for LV wall
thickness factor-height were 0.35 (163 cM) and 2.27 (160
cM), respectively. Since BMI and height were correlated (r = -
0.08, p < 0.05), we cannot rule out the possibility that this
locus is also a pleiotropic locus for height.
There are 161 annotated genes in the 1-LOD-unit support
interval (154 cM to 167 cM) for the peak LOD region on
chromosome 7. Within this interval, we identified two pos-
sible candidates which may contribute to the variation of
LV wall thickness factor and its correlation with BMI: nitric
oxide (NO) synthase 3 (NOS3 or ENOS, 163–164 cM) and
AMP-activated non-catalytic protein kinase γ2 (PRKAG2 or
AMPK-GAMMA-2, 165–166 cM). NOS3 synthesizes NO
and is constitutively expressed in the cardiac myocytes [31].
NO is involved in physiologic processes contributing to
LVH, including vasodilation and production of cardiac
fibroblast extracellular matrix [32]. As mentioned above, a
marker within the NOS3 gene was linked to change in
abdominal total fat after exercise in the HERITAGE Family
Study [30]. The PRKAG2 gene encodes for the γ2 subunit of
AMP-activated protein kinase (AMPK), an enzyme
involved in the modulation of glucose uptake and glycoly-
sis [33]. It has been confirmed that mutations in PRKAG2
cause a novel glycogen storage disease of the heart in which
hypertrophy, ventricular pre-excitation, and conduction
system defects coexist [34]. If the linkage findings on chro-
mosome 7 are replicated in other populations, future stud-
ies that use tagging SNP and/or extensive resequencing
approaches might be able to delineate the role of these
genes in the variation of LV wall thickness and body size
and covariation between them.
We also searched the Framingham 100K genome-wide asso-
ciation study [35] database at the NCBI dbGAP website [36]
and noticed a SNP rs1177946 in a novel gene CNTNAP2
(156–160 cM on chromosome 7) that showed associations
with averaged LV diastolic wall thickness: p = 0.007 after
adjustment for age and gender and 0.01 after additional
adjustment for other risk factors, including height and
weight. This SNP was associated with average BMI at p = 0.03
in the same study. The CNTNAP2 gene encodes a protein
named contactin-associated protein-like 2 (CASPR2).
CASPR is a member of the neurexin superfamily that medi-
ates cell-cell interactions in the nervous system and is also
expressed in the heart. The relevance of CNTNAP2 to LV
hypertrophy is unknown. It is important to note that the
association of rs1177946 with LV diastolic wall thickness or
BMI did not reach statistical significance after adjusting for
multiple testing. Therefore, data presented here can be at best
considered as hypothesis-generating.
In general, we observed different loci for the LV pheno-
types between African Americans and whites. The overall
discrepant results may be explained by differences in pop-
ulation characteristics. Specifically, as shown in Table 1,
all demographic and clinical characteristics are different
between the two groups. The difference in the risk factor
profiles may in part reflect difference in genetic etiology
and/or environmental modifiers that act to modify the
influence of genetic factors. On chromosome 7, there was
no signal for the LV wall thickness factor in African Amer-
icans. This discrepancy may be explained by anthropo-
metric difference between African Americans and whites,
as reflected by larger weight and BMI in African Americans
(Table 1). Given that the locus on chromosome 7 is a plei-
otropic locus for BMI, we may speculate that the genetic
factor related to this locus is more prevalent in AfricanBMC Medical Genetics 2009, 10:40 http://www.biomedcentral.com/1471-2350/10/40
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Americans than whites, leading to the manifestation of
linkage signals in the former group. In addition, the
majority of the participants in our study were hyperten-
sive. As such, the findings of the study might not be able
to be replicated in a general population. Moreover, both
genetic and environmental correlations between LV mass
and BMI and between LV wall thickness factor and BMI
were modest, suggesting that shared genetic and environ-
mental factors contribute less to the additive genetic and
environmental variations than genetic and environmental
factors unique to each phenotype. Finally, factor analysis
is a data reduction technique used to summarize corre-
lated variables. The interpretation of factors and factor
loading pattern are contingent upon the nature of the
phenotypes that are included in the analysis. The derived
factor scores are not clinical phenotypes, but instead sta-
tistical indexes to indicate where an individual stands on
the retained factors. Therefore, factor analysis in genetic
studies should be guided by and interpreted in the context
of physiology and pathophysiology of the phenotypes.
Conclusion
We have observed a locus on chromosome 7 that showed
strong linkage signals for the clustering of LV wall thick-
nesses. This locus also had pleiotropic effects on BMI and
height. There are plausible candidate genes in this region that
may contribute to the increase of LV wall thickness and body
size. If the linkage findings are replicated in other popula-
tions, fine-scale genotyping of the identified region, includ-
ing the candidate genes, is needed to identify the specific
genes and variants that are responsible for the observed link-
age. Identification of the responsible genes offers promise in
understanding novel mechanisms and developing therapeu-
tic strategies in the prevention and treatment of LVH.
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